{"organizations": [], "uuid": "0a24f917527a1d635252ace45b0f964a819a5ace", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-ligand-pharma-says-co-sent-compute/brief-ligand-pharma-says-co-sent-computershare-as-rights-agent-under-glucagon-cvr-agreement-idUSFWN1RQ016", "country": "US", "domain_rank": 408, "title": "BRIEF-Ligand Pharma Says Co Sent Computershare, As Rights Agent Under Glucagon CVR Agreement", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-13T13:25:00.000+03:00", "replies_count": 0, "uuid": "0a24f917527a1d635252ace45b0f964a819a5ace"}, "author": "", "url": "https://www.reuters.com/article/brief-ligand-pharma-says-co-sent-compute/brief-ligand-pharma-says-co-sent-computershare-as-rights-agent-under-glucagon-cvr-agreement-idUSFWN1RQ016", "ord_in_thread": 0, "title": "BRIEF-Ligand Pharma Says Co Sent Computershare, As Rights Agent Under Glucagon CVR Agreement", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-ligand pharma says co sent computershare", "sentiment": "negative"}, {"name": "ligand pharmaceuticals inc", "sentiment": "none"}, {"name": "rights agent under glucagon cvr agreement reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 13, 2018 / 10:26 AM / Updated 8 minutes ago BRIEF-Ligand Pharma Says Co Sent Computershare, As Rights Agent Under Glucagon CVR Agreement Reuters Staff 1 Min Read \nApril 13 (Reuters) - Ligand Pharmaceuticals Inc: \n* LIGAND PHARMACEUTICALS SAYS HOLDERS OF GLUCAGON CVRS ENTITLED TO RECEIVE PRO RATA $3.8 MILLION Source text: ( bit.ly/2JHfcOF ) Further company coverage:", "external_links": [], "published": "2018-04-13T13:25:00.000+03:00", "crawled": "2018-04-13T13:36:13.023+03:00", "highlightTitle": ""}